Phenylephrine Hydrochloride Injection
NDC Package 31722-343-33
Package Information
Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. This formulation utilizes a injection delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-343 and is authorized under FDA application ANDA218110.
Identification & Billing
- RxCUI: 1232651 - phenylephrine HCl 10 MG/ML Injectable Solution
- RxCUI: 1232651 - phenylephrine hydrochloride 10 MG/ML Injectable Solution
- RxCUI: 1232651 - phenylephrine hydrochloride 1 % Injectable Solution
- RxCUI: 1232651 - phenylephrine hydrochloride 100 MG per 10 ML Injectable Solution
- RxCUI: 1232651 - phenylephrine hydrochloride 50 MG per 5 ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 31722 - Camber Pharmaceuticals, Inc.
- 31722-343 - Phenylephrine Hydrochloride
- 31722-343-33 - 25 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE
- 31722-343 - Phenylephrine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (31722-343). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 31722-343-33 identifies a specific commercial package of 25 vial, single-dose in 1 carton / 1 ml in 1 vial, single-dose of Phenylephrine Hydrochloride, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This injection is formulated for intravenous use and contains phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on May 10, 2024. The current certification is valid through December 31, 2026.
How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722034333. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.